This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hsu, H.-C. Articles by Lai, P.-L. Search for Related Content PubMed PubMed Citation Articles by Hsu, H.-C. Articles by Lai, P.-L.

Cloning and Expression of a Developmentally Regulated Transcript MXR7 in Hepatocellular Carcinoma: Biological Significance and Temporospatial Distribution¹

Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan 10001

Using the differential display method to analyze mRNA expression in hepatocellular carcinoma (HCC) and nontumor livers, we cloned a full-length cDNA of 2263 bp, which was designated GTR2-2 and was identical with MXR7. The MXR7 mRNA was detected in 143 of 191 (74.8%) primary and recurrent HCCs taken from 154 patients but only in 5 (3.2%) nontumor livers. MXR7 mRNA was detected in one of two hepatoblastomas but not in hepatocellular adenoma, cholangiocarcinoma, or metastatic carcinomas to the liver. In human cancer of other anatomical sites, MXR7 mRNA was detected in low levels in one Wilms' tumor and in 4 of 40 gastric adenocarcinomas but not in several other types of cancer and 21 nonhepatocellular human tumor cell lines examined. MXR7 mRNA was expressed in high levels in the placenta, fetal liver, lung, and kidney, but it was undetectable in adult liver and was expressed in very low levels in adult lung and kidney. Our observations suggest that the MXR7 gene is regulated developmentally and expressed preferentially in HCC. To study its potential biological significance, we selected 113 patients who had unicentric primary HCC and had been followed for more than 4 years for further analysis. The MXR7 mRNA expression correlated closely with elevated serum -fetoprotein (AFP) levels (88 versus 55%; P = 0.0001) and with expression of AFP mRNA (87 versus 55%; P = 0.005) and CD24 mRNA in HCC (80 versus 50%; P < 0.04), high tumor grade (76 versus 56%; P = 0.05), and tumor invasion (76 versus 55%; P < 0.05), but not with patient outcome. In HCC 3 cm, the frequency (77%) of MXR7 mRNA expression was significantly higher than that of elevated serum AFP (43%; P < 0.007) and AFP mRNA expression in HCC (41%; P < 0.004). Thus, MXR7 may serve as a sensitive early tumor marker for HCC and warrants more study to better understand its biological function.

¹ This work is supported by Grant NSC84-2331-B-002-113 MH from the National Science Council of the Republic of China, Taipei, Taiwan.

² To whom requests for reprints should be addressed, at Department of Pathology, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei, Taiwan 10001. Phone: (886-2) 356-2154; Fax: (886-2) 393-4172.

Received 6/30/97. Accepted 9/22/97.

This article has been cited by other articles:

				S.-Y. Lin, H.-W. Pan, S.-H. Liu, Y.-M. Jeng, F.-C. Hu, S.-Y. Peng, P.-L. Lai, and H.-C. Hsu ASPM Is a Novel Marker for Vascular Invasion, Early Recurrence, and Poor Prognosis of Hepatocellular Carcinoma Clin. Cancer Res., August 1, 2008; 14(15): 4814 - 4820. [Abstract] [Full Text] [PDF]

				W. Cheng, C.-J. Tseng, T. T.C. Lin, I. Cheng, H.-W. Pan, H.-C. Hsu, and Y.-M. Lee Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway Carcinogenesis, July 1, 2008; 29(7): 1319 - 1326. [Abstract] [Full Text] [PDF]

				C.-L. Liu, I-S. Yu, H.-W. Pan, S.-W. Lin, and H.-C. Hsu L2dtl Is Essential for Cell Survival and Nuclear Division in Early Mouse Embryonic Development J. Biol. Chem., January 12, 2007; 282(2): 1109 - 1118. [Abstract] [Full Text] [PDF]

				M. I. Capurro, Y.-Y. Xiang, C. Lobe, and J. Filmus Glypican-3 Promotes the Growth of Hepatocellular Carcinoma by Stimulating Canonical Wnt Signaling Cancer Res., July 15, 2005; 65(14): 6245 - 6254. [Abstract] [Full Text] [PDF]

				T. Nakatsura, H. Komori, T. Kubo, Y. Yoshitake, S. Senju, T. Katagiri, Y. Furukawa, M. Ogawa, Y. Nakamura, and Y. Nishimura Mouse Homologue of a Novel Human Oncofetal Antigen, Glypican-3, Evokes T-Cell-Mediated Tumor Rejection without Autoimmune Reactions in Mice Clin. Cancer Res., December 15, 2004; 10(24): 8630 - 8640. [Abstract] [Full Text] [PDF]

				Y. Hippo, K. Watanabe, A. Watanabe, Y. Midorikawa, S. Yamamoto, S. Ihara, S. Tokita, H. Iwanari, Y. Ito, K. Nakano, et al. Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma Cancer Res., April 1, 2004; 64(7): 2418 - 2423. [Abstract] [Full Text] [PDF]

				Z-W Zhu, H Friess, L Wang, M Abou-Shady, A Zimmermann, A D Lander, M Korc, J Kleeff, and M W Buchler Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders Gut, April 1, 2001; 48(4): 558 - 564. [Abstract] [Full Text] [PDF]

				Y. Yamamoto, M. Sakamoto, G. Fujii, K. Kanetaka, M. Asaka, and S. Hirohashi Cloning and Characterization of a Novel Gene, DRH1, Down-Regulated in Advanced Human Hepatocellular Carcinoma Clin. Cancer Res., February 1, 2001; 7(2): 297 - 303. [Abstract] [Full Text]

				S.-L. Y. Feng, Y. Guo, V. M. Factor, S. S. Thorgeirsson, D. W. Bell, J. R. Testa, K. A. Peifley, and J. A. Winkles The Fn14 Immediate-Early Response Gene Is Induced During Liver Regeneration and Highly Expressed in Both Human and Murine Hepatocellular Carcinomas Am. J. Pathol., April 1, 2000; 156(4): 1253 - 1261. [Abstract] [Full Text] [PDF]